The North America Alopecia Market was worth USD 3.00 Billion in 2021 and is estimated to be growing at a CAGR of 8.21%, to reach USD 4.5 Billion by 2026.
Alopecia is a medical condition that refers to sudden, excessive hair loss on the head area, mostly in circular patches. One such type of alopecia - Alopecia areata is a common autoimmune disease that causes baldness that results in partial or complete hair loss.
The North America Alopecia market growth is primarily fuelled by key factors such as the growing emphasis on aesthetics, the well-established presence of pharmaceutical enterprises working toward the successful treatment of alopecia, rising disposable income, and higher alcohol consumption. The other factors such as the High prevalence of hair loss, chronic disorders related to hair loss, rising healthcare expenditure alopecia treatment are propelling the market growth. The demand for painless treatments with minimum side effects is propelling the treatment rate as people become more aware of hair loss.
Alopecia is caused by several causes, including aging, hormonal imbalance, and the rising prevalence of cancer, arthritis, hypertension, and depression. As a result of the rising prevalence of alopecia, the treatment market is expected to rise significantly in the future years. Therefore, in this region, the number of people seeking alopecia treatment is particularly significant.
Regulatory bodies have approved many innovative medications for the treatment of alopecia, and many more are in the pipeline and expected to be approved soon. For example, in January 2018, the United States Food and Drug Administration (FDA) granted Concert Pharmaceuticals Inc. fast track status for its new medication for the treatment of moderate to severe alopecia areata. The introduction of such innovative products to propel the alopecia treatment market forward in the near future.
However, The North America alopecia market is projected to be hampered by the patent expiration of many blockbuster drugs and the negative effects associated with existing hair loss treatment methods.
This research report on the North America alopecia market has been segmented and sub-segmented into the following categories:
By Disease Type:
By Sales Channel:
By End Use:
North America alopecia market accounts for the largest share due to the availability of technologically advanced healthcare infrastructure, high disposable income, and the presence of novel therapeutics alternatives relevant to the treatments.
The North American alopecia treatment market includes Canada and the United States. Alopecia is treated in Canada by a number of non-profit organizations as well as hair specialist salons. In this context, the Canadian Alopecia Areata Foundation (CANAAF), a charitable organization based in Canada, is primarily dedicated to treating the disorder. It mainly provides assistance to Canadians who have been diagnosed with alopecia areata. The organization also supports autoimmune diseases education and awareness, as well as raising significant funds for research.
The United States is anticipated to witness the largest share of the American Alopecia Market during the forecast period. This is because obesity and stress levels have increased significantly in the United States. Furthermore, the country’s high disposable income and rising consumer spending on grooming items are essential factors. As a result, these factors combined with rising alopecia awareness are expected to drive the growth of the North America alopecia treatment market throughout the forecast period.
According to the United States National Library of Medicine, alopecia areata affects one in every 500 to 1,000 people in the United States are. Alopecia areata, the second most common form of alopecia after androgenetic alopecia, is one of the known forms of alopecia. Men and women alike are affected by alopecia areata, which can affect people of any ethnic background. As a result, the high frequency of hair loss in the United States and the proportionally high treatment rates are important market drivers in the North American alopecia market.
KEY MARKET PLAYERS:
Johnson & Johnson, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd, Shiseido Co., Ltd and Zhangguang 101 Science & Technology Co., Ltd are a few of the noteworthy companies in the North America alopecia market.
1.1 Market Definition
1.2 Scope of the report
1.3 Study Assumptions
1.4 Base Currency, Base Year and Forecast Periods
2. Research Methodology
2.1 Analysis Design
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Data Modelling
2.2.4 Expert Validation
2.3 Study Timeline
3. Report Overview
3.1 Executive Summary
3.2 Key Inferences
4. Market Dynamics
4.1 Impact Analysis
4.2 Regulatory Environment
4.3 Technology Timeline & Recent Trends
5. Competitor Benchmarking Analysis
5.1 Key Player Benchmarking
5.1.1 Market share analysis
5.1.3 Regional Presence
5.2 Mergers & Acquisition Landscape
5.3 Joint Ventures & Collaborations
6. Market Segmentation
6.1 North America Alopecia Market – By Disease Type:
6.1.1 Alopecia Areata
6.1.2 Cicatricial Alopecia
6.1.3 Traction Alopecia
6.1.4 Alopecia Totalis
6.1.5 Alopecia Universalis
6.1.6 Androgenetic Alopecia
6.1.8 Market Size Estimations & Forecasts (2021-2026)
6.1.9 Y-o-Y Growth Rate Analysis
6.1.10 Market Attractiveness Index
6.2 North America Alopecia Market – By Treatment
6.2.3 Market Size Estimations & Forecasts (2021-2026)
6.2.4 Y-o-Y Growth Rate Analysis
6.2.5 Market Attractiveness Index
6.3 North America Alopecia Market – By Gender:
6.3.3 Market Size Estimations & Forecasts (2021-2026)
6.3.4 Y-o-Y Growth Rate Analysis
6.3.5 Market Attractiveness Index
6.4 North America Alopecia Market – By Sales Channel:
6.4.3 Market Size Estimations & Forecasts (2021-2026)
6.4.4 Y-o-Y Growth Rate Analysis
6.4.5 Market Attractiveness Index
6.5 North America Alopecia Market – By End Use:
6.5.1 Homecare Settings
6.5.2 Dermatology Clinics
6.5.3 Market Size Estimations & Forecasts (2021-2026)
6.5.4 Y-o-Y Growth Rate Analysis
6.5.5 Market Attractiveness Index
7. Geographical Landscape
7.1 North America - Market Analysis (2021 - 2026)
7.1.1 By Country
7.1.2 By Disease Type:
7.1.3 By Treatment:
7.1.4 By Gender:
7.1.5 By Sales Channel:
7.1.6 By End Use:
8. Key Player Analysis
8.1 Johnson & Johnson, Inc.
8.1.1 Business Description
8.1.4 SWOT Analysis
8.1.5 Recent Developments
8.1.6 Analyst Overview
8.2 Merck & Co., Inc.
8.3 Teva Pharmaceutical Industries Ltd.
8.4 Dr. Reddy’s Laboratories Ltd.
8.5 Cipla Ltd.
8.6 Cellmid Ltd.
8.7 The Himalaya Drug Company
8.8 Taisho Pharmaceutical Holdings Co., Ltd
8.9 Shiseido Co., Ltd
8.10 Zhangguang 101 Science & Technology Co., Ltd
9. Market Outlook & Investment Opportunities
List of Tables
List of Figures
Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the areas that are still untapped.
The segment-level analysis in terms of disease type, treatment, gender, sales channel, end-use, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.